Handelsbanken Fonder AB - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$137,000
-5.5%
12,7000.0%0.00%0.0%
Q2 2022$145,000
+25.0%
12,7000.0%0.00%0.0%
Q1 2022$116,000
-38.6%
12,7000.0%0.00%0.0%
Q4 2021$189,000
-42.0%
12,7000.0%0.00%
-50.0%
Q3 2021$326,000
-1.5%
12,7000.0%0.00%0.0%
Q2 2021$331,000
-19.9%
12,700
+8.5%
0.00%0.0%
Q1 2021$413,000
+40.0%
11,7000.0%0.00%0.0%
Q4 2020$295,000
-33.1%
11,7000.0%0.00%
-33.3%
Q3 2020$441,000
-56.0%
11,700
-50.0%
0.00%
-25.0%
Q2 2020$1,002,00023,4000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders